Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing and treating schizophrenia

A technology for schizophrenia and composition, which is applied in the directions of drug combination, medical preparations containing active ingredients, and pharmaceutical formulations, etc., can solve the problems of difficult to reach patients, long course of treatment, no dosage form and dosage, etc.

Inactive Publication Date: 2016-05-18
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still many problems in the clinical treatment of schizophrenia with traditional Chinese medicine: (1) The ingredients of traditional Chinese medicine are complex, and there is no scientific and fixed dosage form and dosage. Compared with western medicine, it is more difficult to popularize
(2) The conditions required for the decoction of traditional Chinese medicine are difficult to achieve for many patients, which is extremely inconvenient
(3) The course of traditional Chinese medicine treatment is longer and the effect is slower

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing and treating schizophrenia
  • Pharmaceutical composition for preventing and treating schizophrenia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Embodiment 1: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0036] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 7730g of crakes, 6700g of Zihua Huanghua, 360g of gingkoxanthin, 4430g of 4430g, 500g of Elephantia chinensis;

[0037] Preparation:

[0038] (1) According to the ratio of raw materials, take rail, purple flower yellow flower, ginkgo xanthin, chrysanthemum chrysanthemum, and asteroides, mix them evenly, use ethanol with a concentration of 19.5% by weight as a solvent, and extract by warm soaking at 27.5°C. 24 times, each extraction time is 1.4 hours, each solvent consumption is 31.5 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.16, and filters After that, the medicinal solution passes throu...

Embodiment 2

[0041] Embodiment 2: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0042] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 7700g of crake, 6800g of Zihuahuanghua, 350g of gingkoxanthin, 4440g of 4440g, 400g of Erythrina fruticosa;

[0043] Preparation:

[0044] (1) According to the ratio of raw materials, take rail, purple flower yellow flower, ginkgo xanthin, chrysanthemum chrysanthemum, and asteroides, mix them evenly, use ethanol with a concentration of 19.5% by weight as a solvent, and extract by warm soaking at 27.5°C. 24 times, each extraction time is 1.4 hours, each solvent consumption is 31.5 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.16, and filters After that, the medicinal solution passes through ...

Embodiment 3

[0047] Embodiment 3: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0048] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 7760g of crake, 6600g of Zihua Huanghua, 370g of gingkoxanthin, 4420g of 4420g, and 600g of geranium;

[0049] Preparation:

[0050] (1) According to the ratio of raw materials, take rail, purple flower yellow flower, ginkgo xanthin, chrysanthemum chrysanthemum, and asteroides, mix them evenly, use ethanol with a concentration of 19.5% by weight as a solvent, and extract by warm soaking at 27.5°C. 24 times, each extraction time is 1.4 hours, each solvent consumption is 31.5 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to a relative density of 1.16, and filters After that, the medicinal solution passes through the D3...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses pharmaceutical composition for preventing and treating schizophrenia and a preparation method of the pharmaceutical composition. The pharmaceutical composition is prepared from Rallidae, radix et rhizoma thermopsis, bilobetin, herba saussureae brunneopilosae and Centaurium pulchellum as raw medical materials through matching. The pharmaceutical composition can be prepared in various forms according to a conventional preparation process and has remarkable curative effects on schizophrenia prevention and treatment.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for preventing and treating schizophrenia and a preparation method thereof. Background technique [0002] Schizophrenia is a common mental illness. Most of the onsets are in young adults, manifested as functional impairments in perception, emotion, volitional behavior, and thinking. Mental activities are not coordinated with the surrounding environment and inner experience, and are divorced from reality. General unconsciousness disorder and obvious mental retardation may have cognitive function impairment in attention, working memory, abstract thinking and information integration. The course of the disease is often protracted and recurrent, and some patients suffer from mental activity decline and varying degrees of social function impairment. According to the estimation of the World Health Organization, the lifetim...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/51A61P25/18A61K31/352A61K35/57
CPCA61K35/57A61K9/2013A61K9/2054A61K9/4858A61K31/352A61K36/285A61K36/48A61K36/51A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2236/55
Inventor 不公告发明人
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com